Mural Oncology Plc is a clinical-stage oncology company. It engages in the business of discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company